% alzhub.org library filter % Source: https://alzhub.org/research?author=Janelidze+S % 74 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{warmenhoven2025-39468767, author = {Warmenhoven, N. and Salvadó, G. and Janelidze, S. and Mattsson-Carlgren, N. and Bali, D. and Orduña Dolado, A. and Kolb, H. and Triana-Baltzer, G. and Barthélemy, N. R. and Schindler, S. E. and Aschenbrenner, A. J. and Raji, C. A. and others}, title = {{A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests}}, journal = {Brain}, year = {2025}, doi = {10.1093/brain/awae346}, pmid = {39468767}, url = {https://doi.org/10.1093/brain/awae346} } @article{ossenkoppele2025-40155777, author = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others}, title = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}}, journal = {Nature Aging}, year = {2025}, doi = {10.1038/s43587-025-00835-z}, pmid = {40155777}, url = {https://doi.org/10.1038/s43587-025-00835-z} } @article{karikari2020-32333900, author = {Karikari, T. K. and Pascoal, T. A. and Ashton, N. J. and Janelidze, S. and Benedet, A. L. and Rodriguez, J. L. and Chamoun, M. and Savard, M. and others}, title = {{Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts}}, journal = {The Lancet. Neurology}, year = {2020}, doi = {10.1016/s1474-4422(20)30071-5}, pmid = {32333900}, url = {https://doi.org/10.1016/s1474-4422(20)30071-5} } @article{pereira2021-34259835, author = {Pereira, J. B. and Janelidze, S. and Smith, R. and Mattsson-Carlgren, N. and Palmqvist, S. and Teunissen, C. E. and Zetterberg, H. and Stomrud, E. and others}, title = {{Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab223}, pmid = {34259835}, url = {https://doi.org/10.1093/brain/awab223} } @article{brum2023-37653254, author = {Brum, W. S. and Cullen, N. C. and Janelidze, S. and Ashton, N. J. and Zimmer, E. R. and Therriault, J. and Benedet, A. L. and Rahmouni, N. and Tissot, C. and Stevenson, J. and Servaes, S. and Triana-Baltzer, G. and others}, title = {{A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases}}, journal = {Nature Aging}, year = {2023}, doi = {10.1038/s43587-023-00471-5}, pmid = {37653254}, url = {https://doi.org/10.1038/s43587-023-00471-5} } @article{palmqvist2020-32722745, author = {Palmqvist, S. and Janelidze, S. and Quiroz, Y. T. and Zetterberg, H. and Lopera, F. and Stomrud, E. and Su, Y. and Chen, Y. and others}, title = {{Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders}}, journal = {JAMA}, year = {2020}, doi = {10.1001/jama.2020.12134}, pmid = {32722745}, url = {https://doi.org/10.1001/jama.2020.12134} } @article{janelidze2024-39068669, author = {Janelidze, S. and Barthélemy, N. R. and Salvadó, G. and Schindler, S. E. and Palmqvist, S. and Mattsson-Carlgren, N. and Braunstein, J. B. and Ovod, V. and Bollinger, J. G. and He, Y. and Li, Y. and Raji, C. A. and others}, title = {{Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment}}, journal = {JAMA Neurology}, year = {2024}, doi = {10.1001/jamaneurol.2024.2619}, pmid = {39068669}, url = {https://doi.org/10.1001/jamaneurol.2024.2619} } @article{janelidze2021-33165506, author = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others}, title = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2020.4201}, pmid = {33165506}, url = {https://doi.org/10.1001/jamaneurol.2020.4201} } @article{janelidze2020-32123385, author = {Janelidze, S. and Mattsson, N. and Palmqvist, S. and Smith, R. and Beach, T. G. and Serrano, G. E. and Chai, X. and Proctor, N. K. and others}, title = {{Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia}}, journal = {Nature medicine}, year = {2020}, doi = {10.1038/s41591-020-0755-1}, pmid = {32123385}, url = {https://doi.org/10.1038/s41591-020-0755-1} } @article{janelidze2020-32246036, author = {Janelidze, S. and Stomrud, E. and Smith, R. and Palmqvist, S. and Mattsson, N. and Airey, D. C. and Proctor, N. K. and Chai, X. and others}, title = {{Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease}}, journal = {Nature communications}, year = {2020}, doi = {10.1038/s41467-020-15436-0}, pmid = {32246036}, url = {https://doi.org/10.1038/s41467-020-15436-0} } @article{mattssoncarlgren2020-33068398, author = {Mattsson-Carlgren, N. and Janelidze, S. and Palmqvist, S. and Cullen, N. and Svenningsson, A. L. and Strandberg, O. and Mengel, D. and Walsh, D. M. and others}, title = {{Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2020}, doi = {10.1093/brain/awaa286}, pmid = {33068398}, url = {https://doi.org/10.1093/brain/awaa286} } @article{barthelemy2024-38382645, author = {Barthélemy, N. R. and Salvadó, G. and Schindler, S. E. and He, Y. and Janelidze, S. and Collij, L. E. and Saef, B. and Henson, R. L. and others}, title = {{Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests}}, journal = {Nature medicine}, year = {2024}, doi = {10.1038/s41591-024-02869-z}, pmid = {38382645}, url = {https://doi.org/10.1038/s41591-024-02869-z} } @article{mattsson2016-27694257, author = {Mattsson, N. and Zetterberg, H. and Janelidze, S. and Insel, P. S. and Andreasson, U. and Stomrud, E. and Palmqvist, S. and Baker, D. and others}, title = {{Plasma tau in Alzheimer disease}}, journal = {Neurology}, year = {2016}, doi = {10.1212/wnl.0000000000003246}, pmid = {27694257}, url = {https://doi.org/10.1212/wnl.0000000000003246} } @article{therriault2024-39533113, author = {Therriault, J. and Janelidze, S. and Benedet, A. L. and Ashton, N. J. and Arranz Martínez, J. and Gonzalez-Escalante, A. and Bellaver, B. and Alcolea, D. and others}, title = {{Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability}}, journal = {Nature aging}, year = {2024}, doi = {10.1038/s43587-024-00731-y}, pmid = {39533113}, url = {https://doi.org/10.1038/s43587-024-00731-y} } @article{janelidze2018-30054439, author = {Janelidze, S. and Mattsson, N. and Stomrud, E. and Lindberg, O. and Palmqvist, S. and Zetterberg, H. and Blennow, K. and Hansson, O.}, title = {{CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000006082}, pmid = {30054439}, url = {https://doi.org/10.1212/wnl.0000000000006082} } @article{salvado2025-40952756, author = {Salvadó, G. and Janelidze, S. and Bali, D. and Dolado, A. O. and Therriault, J. and Brum, W. S. and Pichet Binette, A. and Stomrud, E. and Mattsson-Carlgren, N. and Palmqvist, S. and Coomans, E. M. and Teunissen, C. E. and others}, title = {{Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.3217}, pmid = {40952756}, url = {https://doi.org/10.1001/jamaneurol.2025.3217} } @article{leuzy2022-34928318, author = {Leuzy, A. and Smith, R. and Cullen, N. C. and Strandberg, O. and Vogel, J. W. and Binette, A. P. and Borroni, E. and Janelidze, S. and others}, title = {{Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2021.4654}, pmid = {34928318}, url = {https://doi.org/10.1001/jamaneurol.2021.4654} } @article{janelidze2023-36087307, author = {Janelidze, S. and Bali, D. and Ashton, N. J. and Barthélemy, N. R. and Vanbrabant, J. and Stoops, E. and Vanmechelen, E. and others}, title = {{Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2023}, doi = {10.1093/brain/awac333}, pmid = {36087307}, url = {https://doi.org/10.1093/brain/awac333} } @article{janelidze2021-34542571, author = {Janelidze, S. and Teunissen, C. E. and Zetterberg, H. and Allué, J. A. and Sarasa, L. and Eichenlaub, U. and Bittner, T. and Ovod, V. and others}, title = {{Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2021.3180}, pmid = {34542571}, url = {https://doi.org/10.1001/jamaneurol.2021.3180} } @article{nilsson2024-38325331, author = {Nilsson, J. and Pichet Binette, A. and Palmqvist, S. and Brum, W. S. and Janelidze, S. and Ashton, N. J. and Spotorno, N. and Stomrud, E. and others}, title = {{Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases}}, journal = {Brain : a journal of neurology}, year = {2024}, doi = {10.1093/brain/awae032}, pmid = {38325331}, url = {https://doi.org/10.1093/brain/awae032} } @article{cicognola2025-39817469, author = {Cicognola, C. and Salvadó, G. and Smith, R. and Palmqvist, S. and Stomrud, E. and Betthauser, T. J. and Johnson, S. C. and Janelidze, S. and others}, title = {{APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β}}, journal = {Brain : a journal of neurology}, year = {2025}, doi = {10.1093/brain/awaf016}, pmid = {39817469}, url = {https://doi.org/10.1093/brain/awaf016} } @article{palmqvist2019-31233127, author = {Palmqvist, S. and Janelidze, S. and Stomrud, E. and Zetterberg, H. and Karl, J. and Zink, K. and Bittner, T. and Mattsson, N. and others}, title = {{Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.1632}, pmid = {31233127}, url = {https://doi.org/10.1001/jamaneurol.2019.1632} } @article{ashton2021-34099648, author = {Ashton, N. J. and Janelidze, S. and Al Khleifat, A. and Leuzy, A. and van der Ende, E. L. and Karikari, T. K. and Benedet, A. L. and Pascoal, T. A. and others}, title = {{A multicentre validation study of the diagnostic value of plasma neurofilament light}}, journal = {Nature communications}, year = {2021}, doi = {10.1038/s41467-021-23620-z}, pmid = {34099648}, url = {https://doi.org/10.1038/s41467-021-23620-z} } @article{jonaitis2023-37013174, author = {Jonaitis, E. M. and Janelidze, S. and Cody, K. A. and Langhough, R. and Du, L. and Chin, N. A. and Mattsson-Carlgren, N. and Hogan, K. J. and others}, title = {{Plasma phosphorylated tau 217 in preclinical Alzheimer's disease}}, journal = {Brain communications}, year = {2023}, doi = {10.1093/braincomms/fcad057}, pmid = {37013174}, url = {https://doi.org/10.1093/braincomms/fcad057} } @article{pereira2021-34077494, author = {Pereira, J. B. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and van Westen, D. and Dage, J. L. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab163}, pmid = {34077494}, url = {https://doi.org/10.1093/brain/awab163} } @article{collij2024-39277604, author = {Collij, L. E. and Mastenbroek, S. E. and Mattsson-Carlgren, N. and Strandberg, O. and Smith, R. and Janelidze, S. and Palmqvist, S. and Ossenkoppele, R. and Hansson, O.}, title = {{Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease}}, journal = {Nature Communications}, year = {2024}, doi = {10.1038/s41467-024-52299-1}, pmid = {39277604}, url = {https://doi.org/10.1038/s41467-024-52299-1} } @article{janelidze2023-36987840, author = {Janelidze, S. and Barthélemy, N. R. and He, Y. and Bateman, R. J. and Hansson, O.}, title = {{Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios}}, journal = {JAMA neurology}, year = {2023}, doi = {10.1001/jamaneurol.2023.0199}, pmid = {36987840}, url = {https://doi.org/10.1001/jamaneurol.2023.0199} } @article{niimi2024-38778353, author = {Niimi, Y. and Janelidze, S. and Sato, K. and Tomita, N. and Tsukamoto, T. and Kato, T. and Yoshiyama, K. and Kowa, H. and others}, title = {{Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly}}, journal = {Alzheimer's research \& therapy}, year = {2024}, doi = {10.1186/s13195-024-01469-w}, pmid = {38778353}, url = {https://doi.org/10.1186/s13195-024-01469-w} } @article{salvado2026-42189519, author = {Salvadó, G. and Horie, K. and Barthélemy, N. R. and Schindler, S. E. and Janelidze, S. and Orduña Dolado, A. and Bali, D. and Perrin, R. J. and Morris, J. C. and Benzinger, T. L. S. and Gordon, B. A. and Stomrud, E. and others}, title = {{Plasma eMTBR-tau243 and \%p-tau217 for Biological Staging of Alzheimer Disease}}, journal = {JAMA Neurology}, year = {2026}, doi = {10.1001/jamaneurol.2026.1405}, pmid = {42189519}, url = {https://doi.org/10.1001/jamaneurol.2026.1405} } @article{cicognola2021-33773595, author = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00804-9}, pmid = {33773595}, url = {https://doi.org/10.1186/s13195-021-00804-9} } @article{horie2023-37443334, author = {Horie, K. and Salvadó, G. and Barthélemy, N. R. and Janelidze, S. and Li, Y. and He, Y. and Saef, B. and Chen, C. D. and others}, title = {{CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease}}, journal = {Nature medicine}, year = {2023}, doi = {10.1038/s41591-023-02443-z}, pmid = {37443334}, url = {https://doi.org/10.1038/s41591-023-02443-z} } @article{mattssoncarlgren2020-32398359, author = {Mattsson-Carlgren, N. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Strandberg, O. and Smith, R. and Hansson, O.}, title = {{The implications of different approaches to define AT(N) in Alzheimer disease}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000009485}, pmid = {32398359}, url = {https://doi.org/10.1212/wnl.0000000000009485} } @article{gertje2023-36882326, author = {Gertje, E. C. and Janelidze, S. and van Westen, D. and Cullen, N. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N.}, title = {{Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia}}, journal = {Neurology}, year = {2023}, doi = {10.1212/wnl.0000000000207113}, pmid = {36882326}, url = {https://doi.org/10.1212/wnl.0000000000207113} } @article{cullen2021-37117993, author = {Cullen, N. C. and Leuzy, A. and Palmqvist, S. and Janelidze, S. and Stomrud, E. and Pesini, P. and Sarasa, L. and Allué, J. A. and others}, title = {{Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations}}, journal = {Nature aging}, year = {2021}, doi = {10.1038/s43587-020-00003-5}, pmid = {37117993}, url = {https://doi.org/10.1038/s43587-020-00003-5} } @article{janelidze2022-35789365, author = {Janelidze, S. and Christian, B. T. and Price, J. and Laymon, C. and Schupf, N. and Klunk, W. E. and Lott, I. and Silverman, W. and others}, title = {{Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.1740}, pmid = {35789365}, url = {https://doi.org/10.1001/jamaneurol.2022.1740} } @article{janelidze2016-27241045, author = {Janelidze, S. and Stomrud, E. and Palmqvist, S. and Zetterberg, H. and van Westen, D. and Jeromin, A. and Song, L. and Hanlon, D. and others}, title = {{Plasma β-amyloid in Alzheimer's disease and vascular disease}}, journal = {Scientific reports}, year = {2016}, doi = {10.1038/srep26801}, pmid = {27241045}, url = {https://doi.org/10.1038/srep26801} } @article{palmqvist2025-40205199, author = {Palmqvist, S. and Warmenhoven, N. and Anastasi, F. and Pilotto, A. and Janelidze, S. and Tideman, P. and Stomrud, E. and Mattsson-Carlgren, N. and others}, title = {{Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform}}, journal = {Nature medicine}, year = {2025}, doi = {10.1038/s41591-025-03622-w}, pmid = {40205199}, url = {https://doi.org/10.1038/s41591-025-03622-w} } @article{cicognola2021-d7e9adeb, author = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}}, journal = {Alzheimer's Research \& Therapy}, year = {2021}, pmid = {33773595} } @article{leuzy2021-34493616, author = {Leuzy, A. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Jacobs, D. and Cicognola, C. and Stomrud, E. and Vanmechelen, E. and others}, title = {{Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012727}, pmid = {34493616}, url = {https://doi.org/10.1212/wnl.0000000000012727} } @article{mattssoncarlgren2021-33949133, author = {Mattsson-Carlgren, N. and Janelidze, S. and Bateman, R. J. and Smith, R. and Stomrud, E. and Serrano, G. E. and Reiman, E. M. and Palmqvist, S. and others}, title = {{Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau}}, journal = {EMBO molecular medicine}, year = {2021}, doi = {10.15252/emmm.202114022}, pmid = {33949133}, url = {https://doi.org/10.15252/emmm.202114022} } @article{janelidze2016-27042676, author = {Janelidze, S. and Zetterberg, H. and Mattsson, N. and Palmqvist, S. and Vanderstichele, H. and Lindberg, O. and van Westen, D. and Stomrud, E. and others}, title = {{CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease}}, journal = {Annals of clinical and translational neurology}, year = {2016}, doi = {10.1002/acn3.274}, pmid = {27042676}, url = {https://doi.org/10.1002/acn3.274} } @article{pereira2022-37118533, author = {Pereira, J. B. and Janelidze, S. and Strandberg, O. and Whelan, C. D. and Zetterberg, H. and Blennow, K. and Palmqvist, S. and Stomrud, E. and others}, title = {{Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology}}, journal = {Nature aging}, year = {2022}, doi = {10.1038/s43587-022-00310-z}, pmid = {37118533}, url = {https://doi.org/10.1038/s43587-022-00310-z} } @article{janelidze2025-40289884, author = {Janelidze, S. and Ashton, N. J. and Orduña Dolado, A. and Nordström, U. and Bali, D. and Forsberg, K. M. E. and Keskin, I. and Mastrangelo, A. and others}, title = {{A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2025}, doi = {10.1002/alz.70208}, pmid = {40289884}, url = {https://doi.org/10.1002/alz.70208} } @article{brum2024-38486040, author = {Brum, W. S. and Cullen, N. C. and Therriault, J. and Janelidze, S. and Rahmouni, N. and Stevenson, J. and Servaes, S. and Benedet, A. L. and others}, title = {{A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings}}, journal = {Nature communications}, year = {2024}, doi = {10.1038/s41467-024-46603-2}, pmid = {38486040}, url = {https://doi.org/10.1038/s41467-024-46603-2} } @article{janelidze2016-26783546, author = {Janelidze, S. and Hertze, J. and Zetterberg, H. and Landqvist Waldö, M. and Santillo, A. and Blennow, K. and Hansson, O.}, title = {{Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease}}, journal = {Annals of clinical and translational neurology}, year = {2016}, doi = {10.1002/acn3.266}, pmid = {26783546}, url = {https://doi.org/10.1002/acn3.266} } @article{janelidze2015-26511451, author = {Janelidze, S. and Lindqvist, D. and Francardo, V. and Hall, S. and Zetterberg, H. and Blennow, K. and Adler, C. H. and Beach, T. G. and others}, title = {{Increased CSF biomarkers of angiogenesis in Parkinson disease}}, journal = {Neurology}, year = {2015}, doi = {10.1212/wnl.0000000000002151}, pmid = {26511451}, url = {https://doi.org/10.1212/wnl.0000000000002151} } @article{palmqvist2023-35950735, author = {Palmqvist, S. and Stomrud, E. and Cullen, N. and Janelidze, S. and Manuilova, E. and Jethwa, A. and Bittner, T. and Eichenlaub, U. and others}, title = {{An accurate fully automated panel of plasma biomarkers for Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2023}, doi = {10.1002/alz.12751}, pmid = {35950735}, url = {https://doi.org/10.1002/alz.12751} } @article{mendes2024-38195896, author = {Mendes, A. J. and Ribaldi, F. and Lathuiliere, A. and Ashton, N. J. and Janelidze, S. and Zetterberg, H. and Scheffler, M. and Assal, F. and others}, title = {{Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort}}, journal = {Journal of neurology}, year = {2024}, doi = {10.1007/s00415-023-12148-5}, pmid = {38195896}, url = {https://doi.org/10.1007/s00415-023-12148-5} } @article{palmqvist2019-31709776, author = {Palmqvist, S. and Insel, P. S. and Stomrud, E. and Janelidze, S. and Zetterberg, H. and Brix, B. and Eichenlaub, U. and Dage, J. L. and others}, title = {{Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease}}, journal = {EMBO molecular medicine}, year = {2019}, doi = {10.15252/emmm.201911170}, pmid = {31709776}, url = {https://doi.org/10.15252/emmm.201911170} } @article{whelan2019-31694701, author = {Whelan, C. D. and Mattsson, N. and Nagle, M. W. and Vijayaraghavan, S. and Hyde, C. and Janelidze, S. and Stomrud, E. and Lee, J. and others}, title = {{Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease}}, journal = {Acta neuropathologica communications}, year = {2019}, doi = {10.1186/s40478-019-0795-2}, pmid = {31694701}, url = {https://doi.org/10.1186/s40478-019-0795-2} } @article{lu2026-42141098, author = {Lu, L. and Pichet Binette, A. and Hristovska, I. and Janelidze, S. and Smets, B. and Cumplido-Mayoral, I. and Vasanthakumar, A. and Milkovich, B. and An, L. and Ossenkoppele, R. and Krish, V. and others}, title = {{Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease}}, journal = {Nature Aging}, year = {2026}, doi = {10.1038/s43587-026-01123-0}, pmid = {42141098}, url = {https://doi.org/10.1038/s43587-026-01123-0} } @article{cullen2022-34937781, author = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000013228}, pmid = {34937781}, url = {https://doi.org/10.1212/wnl.0000000000013228} } @article{ayton2023-36357168, author = {Ayton, S. and Janelidze, S. and Kalinowski, P. and Palmqvist, S. and Belaidi, A. A. and Stomrud, E. and Roberts, A. and Roberts, B. and others}, title = {{CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2023}, doi = {10.1136/jnnp-2022-330052}, pmid = {36357168}, url = {https://doi.org/10.1136/jnnp-2022-330052} } @article{bali2024-38331843, author = {Bali, D. and Hansson, O. and Janelidze, S.}, title = {{Effects of certain pre-analytical factors on the performance of plasma phospho-tau217}}, journal = {Alzheimer's research \& therapy}, year = {2024}, doi = {10.1186/s13195-024-01391-1}, pmid = {38331843}, url = {https://doi.org/10.1186/s13195-024-01391-1} } @article{berron2024-38867417, author = {Berron, D. and Olsson, E. and Andersson, F. and Janelidze, S. and Tideman, P. and Düzel, E. and Palmqvist, S. and Stomrud, E. and others}, title = {{Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2024}, doi = {10.1002/alz.13919}, pmid = {38867417}, url = {https://doi.org/10.1002/alz.13919} } @article{lindqvist2013-23911592, author = {Lindqvist, D. and Hall, S. and Surova, Y. and Nielsen, H. M. and Janelidze, S. and Brundin, L. and Hansson, O.}, title = {{Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment}}, journal = {Brain, behavior, and immunity}, year = {2013}, doi = {10.1016/j.bbi.2013.07.007}, pmid = {23911592}, url = {https://doi.org/10.1016/j.bbi.2013.07.007} } @article{cullen2021-34117234, author = {Cullen, N. C. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Svenningsson, A. L. and Stomrud, E. and Dage, J. L. and Mattsson-Carlgren, N. and others}, title = {{Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations}}, journal = {Nature communications}, year = {2021}, doi = {10.1038/s41467-021-23746-0}, pmid = {34117234}, url = {https://doi.org/10.1038/s41467-021-23746-0} } @article{pichetbinette2023-36152307, author = {Pichet Binette, A. and Janelidze, S. and Cullen, N. and Dage, J. L. and Bateman, R. J. and Zetterberg, H. and Blennow, K. and Stomrud, E. and others}, title = {{Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2023}, doi = {10.1002/alz.12787}, pmid = {36152307}, url = {https://doi.org/10.1002/alz.12787} } @article{janelidze2022-34151519, author = {Janelidze, S. and Palmqvist, S. and Leuzy, A. and Stomrud, E. and Verberk, I. M. W. and Zetterberg, H. and Ashton, N. J. and Pesini, P. and others}, title = {{Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2022}, doi = {10.1002/alz.12395}, pmid = {34151519}, url = {https://doi.org/10.1002/alz.12395} } @article{yu2023-37031430, author = {Yu, L. and Boyle, P. A. and Janelidze, S. and Petyuk, V. A. and Wang, T. and Bennett, D. A. and Hansson, O. and Schneider, J. A.}, title = {{Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults}}, journal = {Acta neuropathologica}, year = {2023}, doi = {10.1007/s00401-023-02570-4}, pmid = {37031430}, url = {https://doi.org/10.1007/s00401-023-02570-4} } @article{nabers2018-29626112, author = {Nabers, A. and Perna, L. and Lange, J. and Mons, U. and Schartner, J. and Güldenhaupt, J. and Saum, K. U. and Janelidze, S. and others}, title = {{Amyloid blood biomarker detects Alzheimer's disease}}, journal = {EMBO molecular medicine}, year = {2018}, doi = {10.15252/emmm.201708763}, pmid = {29626112}, url = {https://doi.org/10.15252/emmm.201708763} } @article{ayton2021-32882319, author = {Ayton, S. and Janelidze, S. and Roberts, B. and Palmqvist, S. and Kalinowski, P. and Diouf, I. and Belaidi, A. A. and Stomrud, E. and others}, title = {{Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age}}, journal = {Progress in neurobiology}, year = {2021}, doi = {10.1016/j.pneurobio.2020.101904}, pmid = {32882319}, url = {https://doi.org/10.1016/j.pneurobio.2020.101904} } @article{hall2018-30185816, author = {Hall, S. and Janelidze, S. and Surova, Y. and Widner, H. and Zetterberg, H. and Hansson, O.}, title = {{Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders}}, journal = {Scientific reports}, year = {2018}, doi = {10.1038/s41598-018-31517-z}, pmid = {30185816}, url = {https://doi.org/10.1038/s41598-018-31517-z} } @article{skillback2017-28779628, author = {Skillbäck, T. and Delsing, L. and Synnergren, J. and Mattsson, N. and Janelidze, S. and Nägga, K. and Kilander, L. and Hicks, R. and others}, title = {{CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients}}, journal = {Neurobiology of aging}, year = {2017}, doi = {10.1016/j.neurobiolaging.2017.06.028}, pmid = {28779628}, url = {https://doi.org/10.1016/j.neurobiolaging.2017.06.028} } @article{eratne2022-35179048, author = {Eratne, D. and Janelidze, S. and Malpas, C. B. and Loi, S. and Walterfang, M. and Merritt, A. and Diouf, I. and Blennow, K. and others}, title = {{Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives}}, journal = {The Australian and New Zealand journal of psychiatry}, year = {2022}, doi = {10.1177/00048674211058684}, pmid = {35179048}, url = {https://doi.org/10.1177/00048674211058684} } @article{kumar2022-35641311, author = {Kumar, A. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000200605}, pmid = {35641311}, url = {https://doi.org/10.1212/wnl.0000000000200605} } @article{teunissen2025-39625101, author = {Teunissen, C. E. and Kolster, R. and Triana-Baltzer, G. and Janelidze, S. and Zetterberg, H. and Kolb, H. C.}, title = {{Plasma p-tau immunoassays in clinical research for Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2025}, doi = {10.1002/alz.14397}, pmid = {39625101}, url = {https://doi.org/10.1002/alz.14397} } @article{cullen2023-35699240, author = {Cullen, N. C. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Bittner, T. and Suridjan, I. and Jethwa, A. and Kollmorgen, G. and others}, title = {{Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2023}, doi = {10.1002/alz.12706}, pmid = {35699240}, url = {https://doi.org/10.1002/alz.12706} } @article{pereira2021-33279949, author = {Pereira, J. B. and Janelidze, S. and Ossenkoppele, R. and Kvartsberg, H. and Brinkmalm, A. and Mattsson-Carlgren, N. and Stomrud, E. and Smith, R. and others}, title = {{Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awaa395}, pmid = {33279949}, url = {https://doi.org/10.1093/brain/awaa395} } @article{wennstrom2022-34991721, author = {Wennström, M. and Janelidze, S. and Nilsson, K. P. R. and Bank, Netherlands Brain and Serrano, G. E. and Beach, T. G. and Dage, J. L. and Hansson, O.}, title = {{Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels}}, journal = {Acta neuropathologica communications}, year = {2022}, doi = {10.1186/s40478-021-01307-2}, pmid = {34991721}, url = {https://doi.org/10.1186/s40478-021-01307-2} } @article{leuzy2022-34859598, author = {Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Janelidze, S. and Dage, J. L. and Hansson, O.}, title = {{Blood-based biomarkers for Alzheimer's disease}}, journal = {EMBO molecular medicine}, year = {2022}, doi = {10.15252/emmm.202114408}, pmid = {34859598}, url = {https://doi.org/10.15252/emmm.202114408} } @article{johansson2021-33500386, author = {Johansson, M. and Stomrud, E. and Insel, P. S. and Leuzy, A. and Johansson, P. M. and Smith, R. and Ismail, Z. and Janelidze, S. and others}, title = {{Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease}}, journal = {Translational psychiatry}, year = {2021}, doi = {10.1038/s41398-021-01206-z}, pmid = {33500386}, url = {https://doi.org/10.1038/s41398-021-01206-z} } @article{mattssoncarlgren2020-32426454, author = {Mattsson-Carlgren, N. and Andersson, E. and Janelidze, S. and Ossenkoppele, R. and Insel, P. and Strandberg, O. and Zetterberg, H. and Rosen, H. J. and others}, title = {{Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease}}, journal = {Science advances}, year = {2020}, doi = {10.1126/sciadv.aaz2387}, pmid = {32426454}, url = {https://doi.org/10.1126/sciadv.aaz2387} } @article{obara2026-0d68a0e1, author = {Obara, K. and Mastrangelo, A. and Ranieri, A. and Janelidze, S. and Ito, D. and Yamamoto, M. and Vacchiano, V. and Liguori, R. and others}, title = {{Cerebrospinal fluid α-synuclein seed amplification assay positivity identifies a prognostically distinct subgroup in amyotrophic lateral sclerosis}}, journal = {medRxiv}, year = {2026}, doi = {10.64898/2026.10.23.26366349}, url = {https://doi.org/10.64898/2026.10.23.26366349} }